Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Anticholinergic Medications and Cognitive Function in Late Midlife

Limback-Stokin, Martin M.*; Krell-Roesch, Janina, PhD*; Roesler, Kimberly*; Hansen, Allison*; Stonnington, Cynthia M., MD; Temkit, M’hamed, PhD; Caselli, Richard J., MD§; Geda, Yonas E., MD, MSc*,†,§

Alzheimer Disease & Associated Disorders: July-September 2018 - Volume 32 - Issue 3 - p 262–264
doi: 10.1097/WAD.0000000000000251
Brief Reports

*Translational Neuroscience and Aging Program, Mayo Clinic

Departments of Psychiatry and Psychology

Health Sciences Research

§Neurology, Mayo Clinic, Scottsdale, AZ

M.M.L.-S., K.R., and A.H. were summer research interns under the mentorship of Professor Geda at Mayo Clinic, Scottsdale, AZ.

Supported by NIH grants: National Institute of Mental Health (K01 MH068351). The project was also supported by the Robert Wood Johnson Foundation, the Edli Foundation (the Hague, the Netherlands), the Arizona Alzheimer’s Disease Core Center, and the Arizona Alzheimer’s Research Consortium (P30AG19610).

The authors declare no conflicts of interest.

Reprints: Yonas E. Geda, MD, MSc, Neurology and Psychiatry, Mayo Clinic, 13400 E. Shea Blvd., Scottsdale, AZ 85259 (e-mail: geda.yonas@mayo.edu).

Received September 8, 2017

Accepted January 23, 2018

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved